Loading clinical trials...
Loading clinical trials...
Preference study: Genuair® (Pressair™) vs Breezhaler® (Neohaler™) inhalers in patients with COPD
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Almirall, S.A.
Collaborators
NCT07665931 · Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Hyperinflation
NCT07307781 · Chronic Obstructive Pulmonary Disease (COPD)
NCT07402551 · Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
NCT07509606 · Chronic Obstructive Pulmonary Disease (COPD), Whole Body Vibration
NCT07451977 · Chronic Respiratory Failure, Hypoxemia, and more
Almirall investigative site 2
Berlin
Almirall investigative site 1
Munich
Almirall investigative site 3
Barcelona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions